Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005
We congratulate Robin et al1 and Jampel2 on their thought-provoking editorials. Commentaries such as these will stimulate debate and further research, which, in turn, will influence medical treatment and public policy.
The major question raised in both editorials is how to incorporate the results of the Ocular Hypertension Treatment Study (OHTS) into clinical practice.3,4 The authors correctly emphasize that only a minority of ocular hypertensive individuals develop open-angle glaucoma and that even a smaller fraction develop visual impairment or blindness. On this basis, Robin et al1 conclude that there is little reason to treat individuals with ocular hypertension, and they recommend careful follow-up and initiation of treatment after glaucomatous damage is confirmed.
Kass MA, Gordon MO, Kymes SM, Ocular Hypertension Treatment Study. Incorporating the Results of the Ocular Hypertension Treatment Study Into Clinical Practice. Arch Ophthalmol. 2005;123(7):1021–1022. doi:10.1001/archopht.123.7.1021-b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: